Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics Draft Guidance for Industry June 2022 - FDA.gov
6/24/2022 12:00:00 AM2 years 10 months ago
by Center for Drug Evaluation and Research
by Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics Guidance for Industry
Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment on a draft guidance before it begins work on the final version of the gui… [+354 chars]
full article...